These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 5526184)

  • 1. [Indications for anticoagulants in peripheral arteriopathies].
    Housset E; Ricordeau G
    Acquis Med Recent; 1970; ():7-12. PubMed ID: 5526184
    [No Abstract]   [Full Text] [Related]  

  • 2. [Disorders of hemostasis in atherosclerosis in middle-aged and aged patients].
    Titova MI; Ermoliuk RS; Salamov AO; Rudneva VG
    Sov Med; 1990; (9):31-4. PubMed ID: 2267585
    [No Abstract]   [Full Text] [Related]  

  • 3. [Thrombophilia in early and late sclerosis].
    Perlick E
    Z Gesamte Inn Med; 1968 Feb; 23(3):Suppl:33-5 f. PubMed ID: 5672422
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation and management of the thrombosis-prone patient.
    Hoak JC
    Adv Intern Med; 1997; 42():105-37. PubMed ID: 9048118
    [No Abstract]   [Full Text] [Related]  

  • 5. A clinician's view of thrombotic disorders of the cardiovascular system.
    Becker RC
    Arch Pathol Lab Med; 1998 Sep; 122(9):815-6. PubMed ID: 9740141
    [No Abstract]   [Full Text] [Related]  

  • 6. Transradial approach-from the evangelist's view.
    Saito S
    Catheter Cardiovasc Interv; 2001 Jun; 53(2):269-70. PubMed ID: 11387619
    [No Abstract]   [Full Text] [Related]  

  • 7. Anticoagulant therapy: a critique.
    Gross H; Hasson J; Solomon S
    Am Fam Physician; 1971 Jun; 3(6):87-91. PubMed ID: 5580625
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the prophylactic and therapeutic use of anticoagulants].
    Fiori W
    Atti Accad Fisiocrit Siena Med Fis; 1964; 13(2):1017-28. PubMed ID: 5865634
    [No Abstract]   [Full Text] [Related]  

  • 9. Aging, arteriosclerosis and anticoagulants.
    Walsh AC
    Pa Med; 1967 Sep; 70(9):51-6. PubMed ID: 6065566
    [No Abstract]   [Full Text] [Related]  

  • 10. The new anticoagulants: new opportunities, new issues.
    Vlasuk GP
    Arch Pathol Lab Med; 1998 Sep; 122(9):812-4. PubMed ID: 9740140
    [No Abstract]   [Full Text] [Related]  

  • 11. [Oral anticoagulants].
    Palareti G
    Minerva Anestesiol; 1999; 65(1-2 Suppl 1):41-51. PubMed ID: 10206024
    [No Abstract]   [Full Text] [Related]  

  • 12. [Management of heparin-induced thrombocytopenia in a patient on hemodialysis complicated with thrombosis in the extracorporeal circuit].
    César JM; Candela A; Tenorio MT; Chinea A; Sáiz R; Liaño F
    Nefrologia; 2008; 28(4):462-3. PubMed ID: 18662159
    [No Abstract]   [Full Text] [Related]  

  • 13. Low molecular weight heparins for arterial thrombosis.
    Nenci GG; Minciotti A
    Vasc Med; 2000; 5(4):251-8. PubMed ID: 11213238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical management of thrombosis in inherited factor VII deficiency: a description of two cases.
    Arellano-Rodrigo E; Gironella M; Nicolau I; Vila M
    Thromb Haemost; 2009 Feb; 101(2):402-4. PubMed ID: 19190828
    [No Abstract]   [Full Text] [Related]  

  • 15. [Indications and clinical application of thrombosis prophylaxis. I].
    Mittelkötter U; Reith HB; Thiede A
    Zentralbl Chir; 2000; 125(7):W49-52. PubMed ID: 10960979
    [No Abstract]   [Full Text] [Related]  

  • 16. [Long-term therapy with anticoagulants].
    Koller F
    Schweiz Med Wochenschr; 1965 Jun; 95(26):865-9. PubMed ID: 5828867
    [No Abstract]   [Full Text] [Related]  

  • 17. Anticoagulant agents are mainstay therapies in the prevention and treatment of arterial and venous thrombosis. Introduction.
    Nutescu EA
    Am J Manag Care; 2006 Dec; 12(16 Suppl):S427-9. PubMed ID: 17203986
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of arterial thrombosis with low molecular weight heparins.
    Chesebro JH
    Semin Hematol; 1997 Oct; 34(4 Suppl 4):26-34. PubMed ID: 9399407
    [No Abstract]   [Full Text] [Related]  

  • 19. [Some problems in prophylaxis and treatment of thrombotic complications in patients with Marchiafava-Micheli disease].
    Lavrov AA
    Probl Gematol Pereliv Krovi; 1968 Nov; 13(11):13-8. PubMed ID: 5735168
    [No Abstract]   [Full Text] [Related]  

  • 20. NIH Consensus Development Conference. Thrombolytic therapy in thrombosis.
    J Fla Med Assoc; 1980 Nov; 67(11):1021-5. PubMed ID: 7452199
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.